
|Articles|January 16, 2006
Once-daily treatment for psoriasis approved
Advertisement
The FDA has approved Taclonex, a combination topical consisting of calcipotriene 0.005% and betamethasone dipropionate 0.064%, for the treatment of psoriasis vulgaris in adults. Warner Chilcott plans to launch the new ointment in the first half of 2006.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FAQ: The Medicare GLP-1 Bridge—What Independent Pharmacists Need to Know
2
Grocery Pharmacy Conglomerate to Pay $40 Million for Violating False Claims Act
3
Pharmacy Law Lowdown: GLP-1 Compounding
4
HHS Claims ACIP Cannot Meet for Flu Season Due to Ongoing Legal Battle
5



































